Bristol-Myers Squibb

In June 2016, Bristol-Myers Squibb and PsiOxus partnered on a clinical collaboration to evaluate Enadenotucirev in combination with nivolumab to investigate their use in several tumor types (the SPICE Study). View the collaboration announcement.


Back to Top